Combining an anti-HER2 antibody-drug conjugate with an anti-nectin-4 antibody-drug conjugate enhances efficacy in breast cancer and gastric cancer models

Authors: Narjes Yazdi, Negar Pourjamal, Hao Li et al.
Publication: Cancer Cell International
Published: Mar 3, 2026
Source: Crossref
Back to Search View Original Cite This Article

Related Articles

Study of Rongban Tongmai granule on anti-oxidant stress in atherosclerosis

LIN Chengren - Jan 2100

Read More
Cell continuous extraction-HPLC determination biological affinity of 8 bufadienolides on MGC-803 cells and their correlation with anti-tumor activities

JIANG Jiejun - Jan 2100

Read More
USING OF LAB ANIMALS AS A MODEL TO STUDY THE DRUG TOXICITY IN COVID-19

Y.Z. Al-abdaly, R.F Al-Shalchi - Aug 2031

Read More
Anti-corruption campaign and firm dividend policy- the moderating effects of ownership structure

Bo Han Lin, Wei Chuan Wang et al. - Jan 2028

Read More
Deep learning-based face anti-spoofing detection using an efficient dual-unit preprocessing model for secured biometrics

Vijay V. Chakole, Swati R. Dixit - Jan 2027

Read More